Sinopharm Group (02096.HK) repurchased approximately 1,642,000 shares on May 19th at a cost of approximately HK$17,992,700.

Zhixin Finance News App, Xian Sheng Pharmaceutical (02096.HK) announced that on May 19, 2026, it spent approximately 17.9927 million Hong Kong dollars to buy back 164.2 million shares.